An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions

Science Translational Medicine

Volumn 6, Issue 245, 2014, Pages

  Saito, Nao ^a   Qiao, Hongjiang ^a   Yanagi, Teruki ^a   Shinkuma, Satoru ^a   Nishimura, Keiko ^a   Suto, Asuka ^a   Fujita, Yasuyuki ^a   Suzuki, Shotaro ^a   Nomura, Toshifumi ^a   Nakamura, Hideki ^a   Nagao, Koji ^b   Obuse, Chikashi ^b   Shimizu, Hiroshi ^a   Abe, Riichiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; LIPOCORTIN 1; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 2; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; ATM PROTEIN; ATR PROTEIN, HUMAN; CD18 ANTIGEN; CD8 ANTIGEN; PROTEIN BINDING;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MASS SPECTROMETRY; MOUSE; NECROPTOSIS; NONHUMAN; ORDINARY DRUG SKIN REACTION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SUPERNATANT; TOXIC EPIDERMAL NECROLYSIS; ANIMAL; APOPTOSIS; DISEASE MODEL; HELA CELL LINE; METABOLISM; MONONUCLEAR CELL; NECROSIS; PATHOLOGY; SKIN; STEVENS-JOHNSON SYNDROME; ULTRASTRUCTURE;

ANIMALS; ANNEXIN A1; ANTIGENS, CD18; ANTIGENS, CD8; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; DISEASE MODELS, ANIMAL; HELA CELLS; HUMANS; KERATINOCYTES; LEUKOCYTES, MONONUCLEAR; MICE; NECROSIS; PROTEIN BINDING; SKIN; STEVENS-JOHNSON SYNDROME;

EID: 84920520695     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008227     Document Type: Article

References (31)

1. A. Downey, C. Jackson, N. Harun, A. Cooper, Toxic epidermal necrolysis: Review of pathogenesis and management. J. Am. Acad. Dermatol. 66, 995-1003 (2012).
2. W. H. Chung, S. I. Hung, J. Y. Yang, S. C. Su, S. P. Huang, C. Y. Wei, S. W. Chin, C. C. Chiou, S. C. Chu, H. C. Ho, C. H. Yang, C. F. Lu, J. Y. Wu, Y. D. Liao, Y. T. Chen, Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat. Med. 14, 1343-1350 (2008).
3. T. Hanafusa, H. Azukizawa, S. Matsumura, I. Katayama, The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. J. Dermatol. Sci. 65, 213-219 (2012).
4. W. H. Chung, S. I. Hung, Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis. J. Dermatol. Sci. 66, 190-196 (2012).
5. I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler, D. Salomon, T. Hunziker, J. H. Saurat, J. Tschopp, L. E. French, Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490-493 (1998). (Pubitemid 28483679)
6. P. Golstein, G. Kroemer, Cell death by necrosis: Towards a molecular definition. Trends Biochem. Sci. 32, 37-43 (2007). (Pubitemid 46043552)
7. A. Kawahara, T. Kobayashi, S. Nagata, Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 17, 2549-2554 (1998). (Pubitemid 28544695)
8. D. Vercammen, P. Vandenabeele, R. Beyaert, W. Declercq, W. Fiers, Tumour necrosis factorinduced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 9, 801-808 (1997). (Pubitemid 27494144)
9. A. Degterev, Z. Huang, M. Boyce, Y. Li, P. Jagtap, N. Mizushima, G. D. Cuny, T. J. Mitchison, M. A. Moskowitz, J. Yuan, Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112-119 (2005).
10. A. Degterev, J. Hitomi, M. Germscheid, I. L. Ch'en, O. Korkina, X. Teng, D. Abbott, G. D. Cuny, C. Yuan, G. Wagner, S. M. Hedrick, S. A. Gerber, A. Lugovskoy, J. Yuan, Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313-321 (2008). (Pubitemid 351550892)
11. P. S. Welz, A. Wullaert, K. Vlantis, V. Kondylis, V. Fernández- Majada, M. Ermolaeva, P. Kirsch, A. Sterner-Kock, G. van Loo, M. Pasparakis, FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330-334 (2011).
12. C. Günther, E. Martini, N. Wittkopf, K. Amann, B. Weigmann, H. Neumann, M. J. Waldner, S. M. Hedrick, S. Tenzer, M. F. Neurath, C. Becker, Caspase-8 regulates TNF-a-induced epithelial necroptosis and terminal ileitis. Nature 477, 335-339 (2011).
13. A. Beeler, O. Engler, B. O. Gerber, W. J. Pichler, Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J. Allergy Clin. Immunol. 117, 455-462 (2006). (Pubitemid 43190160)
14. A. Rozieres, A. Hennino, K. Rodet, M. C. Gutowski, N. Gunera-Saad, F. Berard, G. Cozon, J. Bienvenu, J. F. Nicolas, Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64, 534-542 (2009).
15. N. Saito, N. Yoshioka, R. Abe, H. Qiao, Y. Fujita, D. Hoshina, A. Suto, S. Kase, N. Kitaichi, M. Ozaki, H. Shimizu, Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients. J. Allergy Clin. Immunol. 131, 434-441.e9 (2013).
16. D. W. Zhang, J. Shao, J. Lin, N. Zhang, B. J. Lu, S. C. Lin, M. Q. Dong, J. Han, RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336 (2009).
17. L. Sun, H. Wang, Z. Wang, S. He, S. Chen, D. Liao, L. Wang, J. Yan, W. Liu, X. Lei, X. Wang, Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227 (2012).
18. Z. Wang, H. Jiang, S. Chen, F. Du, X. Wang, The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228-243 (2012).
19. M. Perretti, F. D'Acquisto, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9, 62-70 (2009).
20. M. Tohyama, H. Watanabe, S. Murakami, Y. Shirakata, K. Sayama, M. Iijima, K. Hashimoto, Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis. Br. J. Dermatol. 166, 322-330 (2012).
21. S. D. Kim, J. M. Kim, S. H. Jo, H. Y. Lee, S. Y. Lee, J. W. Shim, S. K. Seo, J. Yun, Y. S. Bae, Functional expression of formyl peptide receptor family in human NK cells. J. Immunol. 183, 5511-5517 (2009).
22. G. Leoni, A. Alam, P. A. Neumann, J. D. Lambeth, G. Cheng, J. McCoy, R. S. Hilgarth, K. Kundu, N. Murthy, D. Kusters, C. Reutelingsperger, M. Perretti, C. A. Parkos, A. S. Neish, A. Nusrat, Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J. Clin. Invest. 123, 443-454 (2013).
23. C. C. Wentworth, A. Alam, R. M. Jones, A. Nusrat, A. S. Neish, Enteric commensal bacteria induce extracellular signal-regulated kinase pathway signaling via formyl peptide receptor-dependent redox modulation of dual specific phosphatase 3. J. Biol. Chem. 286, 38448-38455 (2011).
24. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, G. Kroemer, Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700-714 (2010).
25. M. A. O'Donnell, E. Perez-Jimenez, A. Oberst, A. Ng, R. Massoumi, R. Xavier, D. R. Green, A. T. Ting, Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 13, 1437-1442 (2011).
26. R. Abe, T. Shimizu, A. Shibaki, H. Nakamura, H. Watanabe, H. Shimizu, Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am. J. Pathol. 162, 1515-1520 (2003). (Pubitemid 36512833)
27. S. J. Posadas, A. Padial, M. J. Torres, C. Mayorga, L. Leyva, E. Sanchez, J. Alvarez, A. Romano, C. Juarez, M. Blanca, Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J. Allergy Clin. Immunol. 109, 155-161 (2002). (Pubitemid 34112146)
28. R. Abe, N. Yoshioka, J. Murata, Y. Fujita, H. Shimizu, Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann. Intern. Med. 151, 514-515 (2009).
29. G. Porebski, T. Pecaric-Petkovic, M. Groux-Keller, M. Bosak, T. T. Kawabata, W. J. Pichler, In vitro drug causality assessment in Stevens-Johnson syndrome-Alternatives for lymphocyte transformation test. Clin. Exp. Allergy 43, 1027-1037 (2013).
30. R. S. Nozawa, K. Nagao, H. T. Masuda, O. Iwasaki, T. Hirota, N. Nozaki, H. Kimura, C. Obuse, Human POGZ modulates dissociation of HP1a from mitotic chromosome arms through Aurora B activation. Nat. Cell Biol. 12, 719-727 (2010).
31. H. M. Miettinen, Regulation of human formyl peptide receptor 1 synthesis: Role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators. PLOS One 6, e28712 (2011).